ERBB2 and breast adenocarcinoma: In the context of breast cancer, studies involving Akt1 knockout mice revealed that the loss of Akt1 suppresses ErbB2-induced mammary carcinogenesis [28] and mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu, MMTV-polyoma middle T transgenic mice [29] and the growth of A2780 ovarian tumors in xenograft models [30].